EVALUATION OF SURVIVAL OUTCOMES OF POST-FRONTLINE ANTI-MYELOMA TREATMENTS IN MULTIPLE MYELOMA PATIENTS BASED ON DATA FROM SEER-MEDICARE DATABASE

被引：0
|
作者：
Nooka, A. [1 ]
Voorhees, P. [2 ]
Kumar, S. [3 ]
Mehra, M. [4 ]
Lam, A. [4 ]
Slavcev, m [4 ]
Ukropec, J. [5 ]
Dasgupta, A. [6 ]
机构：
[1] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Carolinas HealthCare Syst, Levine Canc Inst, Charlotte, NC USA
[3] Mayo Clin, Rochester, MN USA
[4] Janssen Global Serv LLC, Raritan, NJ USA
[5] Janssen Global Serv LLC, Spring House, PA USA
[6] SmartAnalyst Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY30
引用
收藏
页码：A214 / A214
页数：1
相关论文
共 26 条
  • [21] Evolution of Treatment Patterns and Survival Outcomes in European Patients with Multiple Myeloma from 2012-2023 through the Honeur Federated Data Network
    Rueckert, Markus
    Azarias, Guillaume
    Garg, Mamta
    Bygrave, Ceri
    Belcher, Hannah
    Hague, Clare
    Bardenheuer, Kristina
    Vekemans, Wout
    Salomo, Morten
    Otero, Blanca Gros
    Perualila, Nolen
    Van Speybroeck, Michel
    Diels, Joris
    Maisnar, Vladimir
    Spicka, Ivan
    Hajek, Roman
    BLOOD, 2024, 144 : 2388 - 2389
  • [22] Machine Learning-Based Overall Survival Prediction of Elderly Patients With Multiple Myeloma From Multicentre Real-Life Data
    Bao, Li
    Wang, Yu-tong
    Zhuang, Jun-ling
    Liu, Ai-jun
    Dong, Yu-jun
    Chu, Bin
    Chen, Xiao-huan
    Lu, Min-qiu
    Shi, Lei
    Gao, Shan
    Fang, Li-juan
    Xiang, Qiu-qing
    Ding, Yue-hua
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] ASSESSMENT OF THE IMPACT OF POST-AUTOLOGOUS STEM CELL TRANSPLANT MAINTENANCE THERAPY ON SURVIVAL OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN THE COMMUNITY-BASED CONNECT MM REGISTRY
    Jagannath, S.
    Abonour, R.
    Durie, B. G.
    Shah, J. J.
    Narang, M.
    Terebelo, H. R.
    Gasparetto, C. J.
    Toomey, K.
    Hardin, J. W.
    Wagner, L.
    Agarwal, A.
    Srinivasan, S.
    Kitali, A.
    Zafar, F.
    Sturniolo, M.
    Rifkin, R. M.
    HAEMATOLOGICA, 2017, 102 : 507 - 507
  • [24] Safety and Survival Outcomes in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated with Lenalidomide-Based or Non-Lenalidomide-Based Treatments in the Real-World MM-034 Study
    Cavo, Michele
    Dhanasiri, Sujith
    De Stefano, Valerio
    Ramirez Payer, Angel
    Wiesholzer, Martin
    Tromp, Yvonne
    Perera, Meegahage Ratnakanthi
    Richez-Olivier, Valentine
    Gil, Maciej
    Bernasconi, David
    Gamberi, Barbara
    BLOOD, 2022, 140 : 7195 - 7196
  • [25] Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) database
    Kaedbey, Rayan
    Reece, Donna
    Venner, Christopher P.
    Mccurdy, Arleigh
    Su, Jiandong
    Chu, Michael
    Louzada, Martha
    Jimenez-Zepeda, Victor H.
    Mian, Hira
    Song, Kevin
    Sebag, Michael
    Stakiw, Julie
    White, Darrell
    Reiman, Anthony
    Aslam, Muhammad
    Kotb, Rami
    Bergstrom, Debra
    Gul, Engin
    Leblanc, Richard
    EJHAEM, 2024, 5 (03): : 474 - 484
  • [26] RESOURCE UTILISATION AND RELATED HEALTH CARE COSTS AMONG PATIENTS WITH MULTIPLE MYELOMA WITH ≥ 2 PRIOR LINES OF TREATMENT IN FINLAND: EVALUATION BASED ON FINNISH REAL WORLD DATA FROM AURIA BIOBANK
    Kosunen, M.
    Kurki, S.
    Snicker, K.
    Wiik, E.
    VALUE IN HEALTH, 2017, 20 (09) : A498 - A499
123